產品資訊 - Lyophilized Of Rabies Vaccine->aspalthic products

登入

加入會員

求助

Changchun Changsheng Life Sciences Ltd.

	Recommended Results

Lyophilized Of Rabies Vaccine

產品分類 :

化學->化學用品->aspalthic products

產品規格

Model No:	0.5 ml/vial

Country	CN
Minimum Order	5000
Payment Term	L/C,T/T

產品描述

[Drug Name] 
Adopted name: Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried 
[Description] 
The vaccine is a freeze-dried preparation made from the inactivated rabies fixed virus.  The virus grows in Vero  cell cultures.  After cultivation and harvest, the virus suspension is concentrated, 
inactivated, purified, and lyophilized to make the vaccine after the addition of a suitable stabilizer. 
The product looks like a white crisp cake. After reconstitution, it shall turn into a transparent liquid without containing any preservatives. 
Active constituent :  Inactivated rabies fixed virus. Subsidiary materials: All of the subsidiary materials approved shall be listed. 
Diluent: Sterile water for injection 
[Eligibles] 
If a person is bitten or scratched by a rabid dog or other rabid animals, regardless of age or sex,the 
wounds shall be cleaned immediately (Flush the wounds repeatedly with clean water or soap water 
and then apply iodine tincture or ethanol repeatedly to the wounds. ), and the exposed person shall be inoculated with the vaccine according to the postexposure schedule as soon as possible. The 
persons at risk of contacting rabies virus (such as veterinarians, animal breeders, forestry workers, 
workers in slaughterhouse and staffs in rabies laboratory) shall be immunized following the pre-exposure immunization schedule. 
[Action and use] 
The product can induce immunity against rabies virus in recipients following immunization. It is used to prevent rabies. 



 


[Specifications]


0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose. The potency of the vaccine shall be not less than 2.5 IU.


 Postexposure treatment shall be dependent on the following classification of wound severity : 
Category I: Those petting animal, licked by animal on intact skins without  any breaks -Neither 
wound treatment nor administration of vaccine is necessary. 
Category II : Those bitten or scratched by animal on skins but without bleeding - The vaccine shall 
be  administered following  the  postexposure immunization schedule. 
Category III : Those with single or multiple biting wounds on skins with bleeding or scratched with bleeding or mucous membrane contaminated by the saliva of suspected or confirmed rabid animal -The exposed person shall be treated immediately with rabies vaccine, rabies antiserum(40 IU/kg, horse origin) or rabies immunoglobulin ( 20 IU/kg, human origin). If anatomically feasible, 
infiltration injections of the remaining serum (horse or human origin) shall be performed as much as possible around the wound (s); the rest, if any, shall be injected intramuscularly. The rabies antiserum or rabies immunoglobulin is only for single use. 
(4) Pre-exposure immunization schedule:A total of three shots shall be given on days 0, 7 and 21 0r 28. 
(5) Recommendation of boosters for those immunized with rabies vaccine  previously : 
① Complete postexposure immunization schedule was conducted within the recent one year: If bitten by a suspected rabid animal, one does given on days 0 and 3,separately. 
②Complete postexposure immunization schedule was conducted before one year: If bitten by a 
suspected rabid animal, carry out complete immunization schedule again. 
③Complete postexposure immunization schedule was conducted within the last 3 years, and followed by boosters: One dose of vaccine shall be given on days o and 3, separately, if bitten by a 
suspected rabid animal. 
④Complete postexposure immunization schedule and booster (s) were conducted more than three years ago: A complete postexposure immunization schedule shall be executed if bitten by a suspected rabid animal. 


[Feature]


 1. High potency at least 4.0IU/dose


 2. Perfect stability, 3-years shelf life


 3. Fine purification above 99%.


 4. No serious adverse reaction.


 5. Medium can be controlled effectively.


<img src="http://i.bosscdn.com/product/e6/40/1a/52042c3373d7e6bc01c1975301.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=5&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="rabies" alt="rabies" />


 
ccls-vaccine.com

其他類似產品